Potassium chloride
- Generic Name
- Potassium chloride
- Brand Names
- Bi-peglyte, Bss, Bss Ophthalmic Solution, Cardioplegic, Citrasate, Colyte, Dextrose and Electrolyte No. 75, Diphen, Eye Stream, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Glycerolyte 57, Golytely, H.E.L.P.bicel, Hemosate Ultra, Ionosol-MB, Isolyte P, Isolyte S, Isolyte S pH 7.4, Isoplate, K 45, K-tab, Klor-con, Lactated Ringers, Moviprep, Naturalyte, Normosol-R, Nulytely, Nxstage Pureflow, Olimel, Peglyte, Periolimel, Phoxillum, Physiolyte, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Plenvu, Pokonza, Prismasol, Procalamine 3, Ringers, Selectbag One, Suflave, Tis-U-sol
- Drug Type
- Small Molecule
- Chemical Formula
- ClK
- CAS Number
- 7447-40-7
- Unique Ingredient Identifier
- 660YQ98I10
- Background
A white crystal or crystalline powder used as an electrolyte replenisher, in the treatment of hypokalemia, in buffer solutions, and in fertilizers and explosives.
The FDA withdrew its approval for the use of all solid oral dosage form drug products containing potassium chloride that supply 100 mg or more of potassium per dosage unit, except for controlled-release dosage forms and those products formulated for preparation of solution prior to ingestion.
- Indication
For use as an electrolyte replenisher and in the treatment of hypokalemia.
- Associated Conditions
- Dehydration, Dry Mouth, Hypokalemia, Hypotonic Dehydration, Hypovolaemia, Isotonic Dehydration, Markedly Reduced Food Intake, Metabolic Acidosis, Hypodermoclysis, Mild Metabolic acidosis, Mild, moderate Metabolic Acidosis, Ocular edema
- Associated Therapies
- Acid- Base Balance, Bowel preparation therapy, Electrolyte replacement, Fluid replacement therapy, Haemofiltration, Hemodialysis Treatment, Parenteral Nutrition, Parenteral rehydration therapy, Plasma Volume Replacement, Urine alkalinization therapy, Fluid and electrolyte maintenance therapy
Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma
- Conditions
- Melanoma
- Interventions
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 60
- Registration Number
- NCT04988841
- Locations
- 🇫🇷
Hôpital Nantes Hôtel Dieu, Nantes, France
🇫🇷Hôpital Saint Louis, Paris, France
🇫🇷Hôpital Gustave Roussy, Villejuif, France
Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Target Recruit Count
- 100
- Registration Number
- NCT04870905
- Locations
- 🇨🇳
Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China
Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among Inpatients
- First Posted Date
- 2021-01-13
- Last Posted Date
- 2021-01-13
- Lead Sponsor
- University of Bologna
- Target Recruit Count
- 846
- Registration Number
- NCT04708366
- Locations
- 🇮🇹
Policlinico Sant'Orsola-Malpighi, Bologna, Italy
Comparison of Two Preparations for the Study of the Colon Through Colonoscopy
- Conditions
- Colon CancerColon Rectal CancerColon PolypColon Adenoma
- Interventions
- First Posted Date
- 2020-08-04
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- Hospital da Senhora da Oliveira
- Target Recruit Count
- 613
- Registration Number
- NCT04497935
- Locations
- 🇵🇹
Hospital Senhora da Oliveira, Guimarães, Portugal
Effectiveness of PLENVU in the General Screening Population and Patients With IBD
- Conditions
- IBDHealthy
- Interventions
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2020-09-07
- Lead Sponsor
- Johannes Gutenberg University Mainz
- Target Recruit Count
- 290
- Registration Number
- NCT04457934
- Locations
- 🇩🇪
University Hospital Mainz, Mainz, Germany
🇩🇪Dr. Helmut Neumann, Bad Salzuflen, Northrine-Westfalia, Germany
🇩🇪Dr. Horst Hohn, Koblenz, Rhenanie-Palatinate, Germany
QR Code for Endoscopic Bowel Preparation
- Conditions
- Quality Standards in ColonoscopyPatient EducationAcceptance of Bowel-preparation
- Interventions
- First Posted Date
- 2020-07-02
- Last Posted Date
- 2020-09-07
- Lead Sponsor
- Johannes Gutenberg University Mainz
- Target Recruit Count
- 404
- Registration Number
- NCT04456231
- Locations
- 🇩🇪
Dr. Helmut Neumann, Bad Salzuflen, Northrine-Westfalia, Germany
The Effect of Fluids on Aortic VTI During C-section
- Conditions
- Fluid OverloadLabor ComplicationPregnancy RelatedHemorrhage
- Interventions
- First Posted Date
- 2020-04-01
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT04330742
- Locations
- 🇺🇸
Ben Taub General Hospital, Houston, Texas, United States
Potassium Chloride in Out-of-hospital Cardiac Arrest Due to Refractory Ventricular Fibrillation
- Conditions
- Out-of-hospital Cardiac Arrest (OHCA)
- Interventions
- First Posted Date
- 2020-03-20
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Registration Number
- NCT04316611
- Locations
- 🇫🇷
AP-HP - SAMU de Paris, Paris, France
Two Low Volume Regimens for Colorectal Cancer Screening Colonoscopy
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Hospital Clinic of Barcelona
- Target Recruit Count
- 1002
- Registration Number
- NCT04297423
- Locations
- 🇪🇸
Hospital CLinic, Barcelona, Catalonia, Spain
The Use of Osmotic Laxatives Versus Macrogol for Bowel Preparation in Patients Undergoing Colonoscopy
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Russian Society of Colorectal Surgeons
- Target Recruit Count
- 98
- Registration Number
- NCT04225793
- Locations
- 🇷🇺
Clinic of Colorectal and Minimally invasive surgery, Moscow, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.